AI Portfolio Summary
In 2025 Q4, Prosight Management, LP maintained a portfolio of 53 distinct positions. The most significant new addition to the portfolio was NEKTAR THERAPEUTICS, which now represents 4.85% of the total fund value. They heavily accumulated shares in PROCEPT BIOROBOTICS , increasing their position by 1692.4%. Conversely, Prosight Management, LP completely exited their position in INTUITIVE SURGICAL I.
Total Positions
53
Quarter
2025 Q4
Top Holding
PRCT (9.0%)
Top 10 Concentration
57.2%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
1-25 of 53
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
PRCT
PROCEPT BIOROBO...
|
Healthcare | 8.97% | 0.64% |
#1
28
Prev: #29
|
5.9 | 1,303,009 | 1692.4% |
P
S
|
1,380,000 | $43,414,800 | 2021 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
GLPG
GALAPAGOS NV
|
Healthcare | 7.26% | 9.29% |
#2
1
Prev: #1
|
2.9 | -75,888 | -6.6% |
P
S
|
1,074,112 | $35,123,462 | 2018 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
JANX
JANUX THERAPEUT...
|
Healthcare | 6.82% | 4.93% |
#3
3
Prev: #6
|
5.0 | 1,527,173 | 176.5% |
P
S
|
2,392,523 | $33,016,817 | 2024 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ADCT
ADC THERAPEUTIC...
|
Healthcare | 6.18% | 6.97% |
#4
1
Prev: #3
|
4.5 | 1,005,035 | 13.5% |
P
S
|
8,477,338 | $29,925,003 | 2022 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
KURA
KURA ONCOLOGY I...
|
Healthcare | 5.43% | 5.69% |
#5
1
Prev: #4
|
2.2 | -228,916 | -8.3% |
P
S
|
2,529,600 | $26,282,544 | 2018 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MGTX
MEIRAGTX HLDGS ...
|
Healthcare | 5.27% | 7.85% |
#6
4
Prev: #2
|
2.2 | -879,721 | -21.5% |
P
S
|
3,209,788 | $25,517,815 | 2018 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NKTR
NEKTAR THERAPEU...
|
Healthcare | 4.85% | — |
#7
Prev: #—
|
3.9 | 554,633 | no change |
NEW
|
554,633 | $23,449,883 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
VEEV
VEEVA SYS INC
|
Healthcare | 4.16% | — |
#8
Prev: #—
|
3.7 | 90,133 | no change |
NEW
|
90,133 | $20,120,390 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ICLR
ICON PLC
|
Healthcare | 4.14% | 4.47% |
#9
1
Prev: #8
|
3.7 | 500 | 0.5% |
P
S
|
110,000 | $20,044,200 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BSX
BOSTON SCIENTIF...
|
Healthcare | 4.14% | 1.73% |
#10
12
Prev: #22
|
4.0 | 133,900 | 176.0% |
P
S
|
210,000 | $20,023,500 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CON
CONCENTRA GROUP...
|
Healthcare | 3.62% | 2.98% |
#11
5
Prev: #16
|
3.6 | 281,030 | 46.1% |
P
S
|
891,030 | $17,535,470 | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PHR
PHREESIA INC
|
Healthcare | 3.42% | — |
#12
Prev: #—
|
3.4 | 977,152 | no change |
NEW
|
977,152 | $16,533,412 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
FOLD
AMICUS THERAPEU...
|
Healthcare | 3.38% | 3.14% |
#13
1
Prev: #12
|
1.5 | -559,533 | -32.7% |
P
S
|
1,150,000 | $16,376,000 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SEM
SELECT MED HLDG...
|
Healthcare | 3.18% | 2.62% |
#14
5
Prev: #19
|
3.3 | 160,171 | 18.3% |
P
S
|
1,035,086 | $15,371,027 | 2022 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SNDX
SYNDAX PHARMACE...
|
Healthcare | 2.89% | 3.60% |
#15
6
Prev: #9
|
1.3 | -338,400 | -33.7% |
P
S
|
665,000 | $13,971,650 | 2024 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ZYME
ZYMEWORKS INC
|
Healthcare | 2.89% | 2.99% |
#16
1
Prev: #15
|
1.2 | -219,218 | -29.2% |
P
S
|
530,393 | $13,965,248 | 2023 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ROIV
ROIVANT SCIENCE...
|
Healthcare | 2.81% | 4.71% |
#17
10
Prev: #7
|
1.3 | -708,338 | -53.0% |
P
S
|
627,162 | $13,609,415 | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CRNX
CRINETICS PHARM...
|
Healthcare | 2.53% | 3.19% |
#18
7
Prev: #11
|
1.1 | -65,780 | -20.0% |
P
S
|
262,904 | $12,238,181 | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AVTR
AVANTOR INC
|
Healthcare | 2.13% | — |
#19
Prev: #—
|
2.9 | 898,499 | no change |
NEW
|
898,499 | $10,296,799 | 2022 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
STTK
SHATTUCK LABS I...
|
Healthcare | 1.80% | 3.04% |
#20
6
Prev: #14
|
0.9 | -3,069,693 | -56.3% |
P
S
|
2,381,502 | $8,692,482 | 2021 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
LH
LABCORP HOLDING...
|
Healthcare | 1.79% | — |
#21
Prev: #—
|
2.7 | 34,532 | no change |
NEW
|
34,532 | $8,663,388 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
WGS
GENEDX HOLDINGS...
|
Healthcare | 1.48% | — |
#22
Prev: #—
|
2.6 | 55,000 | no change |
NEW
|
55,000 | $7,153,300 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ALNY
ALNYLAM PHARMAC...
|
Healthcare | 1.41% | — |
#23
Prev: #—
|
2.6 | 17,109 | no change |
NEW
|
17,109 | $6,803,394 | 2021 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IMVT
IMMUNOVANT INC
|
Healthcare | 1.28% | 2.63% |
#24
6
Prev: #18
|
0.7 | -455,068 | -65.2% |
P
S
|
243,404 | $6,187,330 | 2019 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CRBP
CORBUS PHARMACE...
|
Healthcare | 1.15% | 1.01% |
#25
2
Prev: #27
|
2.8 | 340,472 | 99.1% |
P
S
|
683,872 | $5,566,718 | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ISRG
INTUITIVE SURGI...
|
Healthcare | 0.00% | 5.08% |
Sold All 😨
(Was: #5) |
0.3 | -48,711 | -100.0% |
CLOSED
|
— | $— | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
DXCM
DEXCOM INC
|
Healthcare | 0.00% | 3.06% |
Sold All 😨
(Was: #13) |
0.3 | -195,217 | -100.0% |
CLOSED
|
— | $— | 2017 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
N/A
CALL
CORCEPT THERAPE...
|
—
|
CALL Option | 0.00% | 2.86% |
Sold All 😨
(Was: #17) |
0.3 | -147,800 | -100.0% |
CLOSED
|
— | $— | — | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | ||
|
BHVN
BIOHAVEN LTD
|
Healthcare | 0.00% | 2.10% |
Sold All 😨
(Was: #20) |
0.3 | -600,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
VRTX
VERTEX PHARMACE...
|
Healthcare | 0.00% | 1.87% |
Sold All 😨
(Was: #21) |
0.3 | -20,500 | -100.0% |
CLOSED
|
— | $— | 2020 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ACHC
ACADIA HEALTHCA...
|
Healthcare | 0.00% | 1.44% |
Sold All 😨
(Was: #24) |
0.3 | -250,000 | -100.0% |
CLOSED
|
— | $— | 2017 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ALGN
ALIGN TECHNOLOG...
|
Healthcare | 0.00% | 0.57% |
Sold All 😨
(Was: #30) |
0.3 | -19,442 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ARGX
ARGENX SE
|
Healthcare | 0.00% | 0.57% |
Sold All 😨
(Was: #31) |
0.3 | -3,300 | -100.0% |
CLOSED
|
— | $— | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TWST
TWIST BIOSCIENC...
|
Healthcare | 0.00% | 0.49% |
Sold All 😨
(Was: #32) |
0.3 | -75,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AKRO
AKERO THERAPEUT...
|
Healthcare | 0.00% | 0.43% |
Sold All 😨
(Was: #33) |
0.3 | -39,072 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CTMX
CYTOMX THERAPEU...
|
Healthcare | 0.00% | 0.42% |
Sold All 😨
(Was: #34) |
0.3 | -564,800 | -100.0% |
CLOSED
|
— | $— | 2024 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SGHT
SIGHT SCIENCES ...
|
Healthcare | 0.00% | 0.35% |
Sold All 😨
(Was: #35) |
0.3 | -439,941 | -100.0% |
CLOSED
|
— | $— | 2024 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SDGR
SCHRODINGER INC
|
Healthcare | 0.00% | 0.16% |
Sold All 😨
(Was: #37) |
0.3 | -34,830 | -100.0% |
CLOSED
|
— | $— | 2024 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PRTA
PROTHENA CORP P...
|
Healthcare | 0.00% | 0.05% |
Sold All 😨
(Was: #40) |
0.3 | -20,000 | -100.0% |
CLOSED
|
— | $— | 2020 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ACTU
ACTUATE THERAPE...
|
Healthcare | 0.00% | 0.00% |
Sold All 😨
(Was: #42) |
0.3 | -885 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) |
Showing 1-25 of 53 holdings